Background Soluble receptor for advanced glycation end products (sRAGE) is a proposed
emphysema and airflow obstruction biomarker; however, previous publications have shown …

Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease
that has been traditionally characterized by incompletely reversible airflow limitation. Yet, the …

Background The receptor for advanced glycation end products (RAGE) is a multiligand
signal transduction receptor that can initiate and perpetuate inflammation. Its soluble isoform …

The soluble receptor for advanced glycation end-products (sRAGE) has anti-inflammatory
properties, and deficiency of circulating sRAGE is associated with various human diseases …

Abstract Rationale Plasma soluble Receptor for Advanced Glycation End Product (sRAGE)
is considered as a biomarker in COPD. The contribution of endogenous sRAGE (esRAGE) …

Background The receptor for advanced glycation end-products (RAGE) is highly expressed
in the lung, where it is believed to have a homeostatic role. Reduced plasma levels of …

Rationale: Emphysema in chronic obstructive pulmonary disease (COPD) can be
characterized by high-resolution chest computed tomography (HRCT); however, the …

Several studies have found that systemic soluble receptor for advanced glycation end-
products (sRAGE) levels are decreased in COPD patients and strongly correlate with lung …

Background Chronic obstructive pulmonary disease (COPD) is a chronic lung disease
characterized by chronic airway inflammation and emphysema, and is caused by exposure …

Background Chronic obstructive pulmonary disease (COPD) is accompanied by an
increased cardiovascular risk which is aggravated by the incidence of acute exacerbations …